USP Seeks Comments on Four Excipient Monographs

News
Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Pharmacopeia is revising its monographs for four pharmaceutical excipients: propylene glycol, sorbitol solution, sorbitol sorbitan solution, and noncrystalllizing sorbitol solution.

The US Pharmacopeia is revising its monographs for four pharmaceutical excipients: propylene glycol, sorbitol solution, sorbitol sorbitan solution, and noncrystalllizing sorbitol solution. USP posted draft compendial methods for these monographs for public comment.

According to USP, the revisions are part of the organization’s efforts to prevent future diethylene glycol (DEG) and ethylene glycol (EG) adulteration of these excipients. In addition to changing the exipient monographs, USP developed two new impurities reference standards for DEG and EG.

DEG-contaminated glycerin used in the manufacture of acetaminophen syrup in Haiti between November 1995 and June 1996 was responsible for most of the subsequent cases of acute renal failure diagnosed in 86 children, according to the Centers for Disease Control. In 2007, DEG was also discovered in toothpaste originating from China.

Comments on the four excipient monographs are due by August 14, 2009. USP says it also will post a proposed method for maltitol solution in the near future.

See these related PharmTech articles:

FDA Issues Guidance for Testing for DEG-Contaminated Glycerin (ePT newsletter)

Excipient Control Strategies (Primer: A Guide to Managing the Supply Chain, supplement to PharmTech's October 2008 issue)

Excipient Control Strategies in China (CPhI Focus newsletter)

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes